We have fractionated crude porcine heparin to obtain highly active as well as relatively inactive species of molecular weight ≈ 7000 with specific anticoagulant activities of 360 and 12 units/mg, ...

Researchers at the University of North Carolina at Chapel Hill have patented a synthetic version of the drug heparin, called Recomparin, that is less complex chemically and should be easier to produce ...

Heparin was the first anticoagulant agent to be discovered and isolated for medical use, and is one of the oldest drugs still to be in widespread clinical use. Indeed, heparin remains on the WHO Model ...

A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein ...

Heparin plays a key role in allergic and inflammatory reactions driven by mast cells, scientists have found. The study, conducted by scientists from Karolinska Institutet in Sweden in collaboration ...

Cell adhesion to extracellular matrix components such as fibronectin has a complex basis, involving multiple determinants on the molecule that react with discrete cell surface macromolecules. Our ...

A new study could change the treatment course for hundreds of thousands of patients, saving lives and preventing complications. Bivalirudin is a safer and more effective anticoagulant than heparin for ...

Research and Markets (http://www.researchandmarkets.com/research/f9k5fz/global_heparin) has announced the addition of the "Global Heparin Market 2015-2019" report to ...